Hydroxychloroquine enhances insulin sensitivity and ameliorates abnormal lipid metabolism in obese women with polycystic ovary syndrome

Hydroxychloroquine enhances insulin sensitivity and ameliorates abnormal lipid metabolism in obese women with polycystic ovary syndrome

Abstract Background Hydroxychloroquine (HCQ) is frequently utilized in rheumatic immune disorders and has been discovered to exert hypoglycemic effects in some obese women with polycystic ovary syndrome(PCOS), however, the precise efficacy and mechanism of action remain ambiguous. Objective To exami...

Full description

Saved in:
Bibliographic Details
Main Authors: Ruihan Wang, Shanqin Qi, Qi Wang, Jiajia Lang, Conghui Pang, Kehua Wang
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Endocrine Disorders
Subjects:
Hydroxychloroquine
Polycystic ovary syndrome
Insulin resistance
Lipid metabolism
Online Access:https://doi.org/10.1186/s12902-024-01827-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items